Trend Results : Kettering Cancer Center


Blog Post Results (1-20 of 74)

FILTER RESULTS

World-Renowned Medical Oncologist Luis Diaz, MD, Named Head of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center

Luis A. Diaz, MD, has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz most recently served as an associate professor of oncology at the Johns Hopkins University School of Medicine.

Memorial Sloan Kettering Expertise on Precision Medicine Highlighted in American Association for Cancer Research Annual Meeting Press Program

Research findings from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year's American Association for Cancer Research (AACR) Annual Meeting press program. The AACR is the oldest and largest professional organization...Show More Summary

MSK Researchers Identify First Evidence of Epigenetic Role in Breast Cancer

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer. The team found that inhibition of the PI3K pathway leads to activation of ER-dependent transcription through the epigenetic regulator KMT2D. Show More Summary

Jeffrey A. Drebin, MD, PhD, Named Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center

Jeffrey A. Drebin, MD, PhD, has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Drebin brings to MSK decades of experience as a world-class surgical oncologist specializing in pancreaticobiliary, upper gastrointestinal and liver surgery.

CAR T cells more powerful when built with CRISPR, MSK researchers find

(Memorial Sloan Kettering Cancer Center) Researchers from Memorial Sloan Kettering Cancer Center have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen receptor (CAR) T cells that enhance tumor rejection in m...

Memorial Sloan Kettering Researchers Publish Roadmap to Precision Oncology

Researchers from Memorial Sloan Kettering Cancer Center (MSK) today published a seminal review of the rapidly evolving field of precision oncology, which allows doctors to recommend therapies based on a genetic understanding of a person's cancer. Show More Summary

Seven Bridges to Present on Cancer Moonshot’s Blood Profiling Atlas at Precision Medicine World Congress

3 months agoTechnology : Venture Beat

PRESS RELEASE: Seven Bridges, the biomedical data analysis company, today announced that its Senior VP of Commercial Operations, Bruce Press, will join Dr. Howard Scher of Memorial Sloan Kettering Cancer Center and Dr. Geoff Otto of Foundation...

Memorial Sloan Kettering Debuts in Monmouth County

Nearly 20 years have passed since Memorial Sloan Kettering Cancer Center (MSK) first opened its doors in the Garden State. Since then, an explosion of knowledge and data has resulted in far better outcomes for thousands of people with cancer, including many who've sought care at MSK's facility in New Jersey.

Memorial Sloan Kettering opens cancer center in New Jersey

A top-ranked New York City hospital is opening a cancer center in New Jersey. State and medical officials will be on hand Monday at Memorial Sloan Kettering Cancer Center in Middletown. The... To view the full story, click the title link.

Memorial Sloan Kettering Launches MSK Direct to Expand Access to World-Class Cancer Care

In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center (MSK) has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with the institution for initial or ongoing cancer care.

NY Cancer Center, Taps Medidata to Test Wearables in Oncology Care

Memorial Sloan Kettering Cancer Center (MSK) is collaborating with Medidata, a provider of cloud-based solutions for clinical research in life sciences to expand the use of mobile health technology in oncology treatment. Through theShow More Summary

Men with Metastatic Prostate Cancer Should Be Considered for Germline Genetic Testing of DNA Repair Genes

Men with metastatic prostate cancer should be considered for germline genetic testing of DNA repair genes, regardless of age or family history, according to a team of researchers from Memorial Sloan Kettering Cancer Center (MSK), Fred...Show More Summary

Andrew L. Kung, MD, PhD, Named Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center

Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the...Show More Summary

Build A Tribe And Sales Will Follow. Learning From “Humans of New York” Photog

Humans of New York photographer Brandon Stanton is using his viral fundraising prowess to help pediatric cancer patients at Memorial Sloan Kettering Cancer Center, reports Crains NY. Sure, with 17.6 million Facebook users and 5.3 million Instagram followers it’s pretty “easy” to raise millions for a cause. Show More Summary

Online Community ‘Humans of New York’ Raises $3.5 Million For Pediatric Cancer Research

11 months agoNews : Mediaite

This time, during a series on Memorial Sloan Kettering Cancer Center's pediatric unit, he and his followers outdid themselves. 97,541 people raised $3,597,495 in 15 days.

Humans of New York's viral pediatric cancer campaign raises over $3.6 million for Memorial Sloan Kettering

Humans of New York photographer Brandon Stanton is using his viral fundraising prowess to help pediatric cancer patients at Memorial Sloan Kettering Cancer Center. The 32-year-old blogger had helped... To view the full story, click the title link.

Memorial Sloan Kettering Expands into Northern New Jersey

Memorial Sloan Kettering Cancer Center (MSK) will further enhance its ability to offer top cancer care to even more patients with the establishment of a freestanding, state-of-the-art outpatient treatment center in Bergen County, New Jersey. Show More Summary

Richard J. O'Reilly, MD, Named The Society of Memorial Sloan Kettering's Inaugural Prize Winner for Groundbreaking Contributions in Pediatric Oncology

The Society of Memorial Sloan Kettering Cancer Center (MSK) has announced that Richard J. O'Reilly, MD, has been named the inaugural recipient of The Society of Memorial Sloan Kettering Prize. This new award recognizes an individual who has made outstanding contributions to the field of pediatric oncology.

Memorial Sloan Kettering Researcher's Promising Entrectinib Clinical Trial Data Highlighted at American Association for Cancer Research Annual Meeting

Encouraging clinical trial data from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year's American Association for Cancer Research (AACR) Annual Meeting press program and presented as part of the Precision Medicine Early Clinical Trial Plenary Session.

Incidence of diagnosed thyroid cancer may be leveling off

In a study published online by JAMA Otolaryngology-Head & Neck Surgery, Luc G. T. Morris, M.D., M.Sc., of Memorial Sloan Kettering Cancer Center, New York, and colleagues analyzed the incidence of thyroid cancer in the U.S. from 1983 to 2012. Show More Summary

Copyright © 2015 Regator, LLC